Marginal zone B cells are critical to factor VIII inhibitor formation in mice with hemophilia A

Although factor VIII (FVIII) replacement therapy can be lifesaving for patients with hemophilia A, neutralizing alloantibodies to FVIII, known as inhibitors, develop in a significant number of patients and actively block FVIII activity, making bleeding difficult to control and prevent. Although a va...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Blood
Päätekijät: Zerra, Patricia E., Cox, Courtney, Baldwin, W. Hunter, Patel, Seema R., Arthur, Connie M., Lollar, Pete, Meeks, Shannon L., Stowell, Sean R.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society of Hematology 2017
Aiheet:
Thrombosis and Hemostasis
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5721282/
https://ncbi.nlm.nih.gov/pubmed/28978569
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2017-05-782912
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia